Tutorials
FRA:BVF (Canada)  
Bausch Health Companies Inc logo

Bausch Health Companies Inc

€ 5.74 (+0.91%) Aug 12
P/E:
51.61
P/B:
0
Market Cap:
€ 2.11B ($ 2.15B)
Enterprise V:
€ 22.61B ($ 23.05B)
Volume:
380.00
Avg Vol (2M):
2.81K
Also Trade In:
Volume:
380.00
Market Cap €:
2.11B
Market Cap $:
2.15B
PE Ratio:
51.61
Avg Vol (2-Month):
2.81K
Enterprise Value €:
22.61B
Enterprise Value $:
23.05B
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Bausch Health Companies Inc
NAICS : 325412 SIC : 3741
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Description
Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Bausch+Lomb (45% of revenue), Salix Pharmaceuticals (24%), international pharma (14%), ortho dermatology (7%), and diversified products (10%). Bausch is the market leader in consumer visioncare in India and China and the fourth-largest visioncare company by sales in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.03
Equity-to-Asset -0.03
Debt-to-Equity -31.48
Debt-to-EBITDA 7.47
Interest Coverage 1
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.07
Distress
Grey
Safe
Beneish M-Score -2.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 53.86
9-Day RSI 45.64
14-Day RSI 42.56
6-1 Month Momentum % -62.67
12-1 Month Momentum % -63.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.08
Quick Ratio 0.87
Cash Ratio 0.13
Days Inventory 162.82
Days Sales Outstanding 73.61
Days Payable 71.65

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.9

Financials (Next Earnings Date:2022-11-02 Est.)

FRA:BVF's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 7,340.136
EPS (TTM) (€) 0.059
Beta 1.3
Volatility % 65.45
14-Day RSI 42.56
14-Day ATR (€) 0.548836
20-Day SMA (€) 6.61065
12-1 Month Momentum % -63.52
52-Week Range (€) 4.305 - 25.07
Shares Outstanding (Mil) 361.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bausch Health Companies Inc Filings

Document Form Filing Date
No Filing Data